With surgical techniques applicable to many stages of kidney cancer, it is important for patients to discuss these options with their cancer team to select the best approach for their disease. With ...
Five-year recurrence-free rates of 89.4% and 83.9% indicate durable disease control after ProSense cryoablation in localized ...
In this episode of From Bench to Bedside and Beyond, Dr. Yaw Nyame and patient Dave Lucas discuss the robotic surgical ...
Please provide your email address to receive an email when new articles are posted on . First phase 3 study to show a survival benefit with adjuvant therapy in kidney cancer. Adjuvant pembrolizumab ...
With multiple game-changing developments over the past two decades, kidney cancer patients are now living longer and better. A big part of the reason is that many are being diagnosed at earlier stages ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In 2024, the treatment landscape for kidney cancer ...
Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of recurrence after surgery showed significantly improved disease-free survival when ...
For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer. Treatment ...
Times Insider explains who we are and what we do and delivers behind-the-scenes insights into how our journalism comes ...
FARGO - John Puckropp felt a dull pain in his left side and immediately suspected a return bout of kidney stones. After landing the passenger jet he piloted from the Twin Cities to Sheridan, Wyo., he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results